Background Two thirds of children with tuberculosis have nonsevere disease, which may be
treatable with a shorter regimen than the current 6-month regimen. Methods We conducted …

Background The safety, efficacy, and appropriate timing of isoniazid therapy to prevent
tuberculosis in pregnant women with human immunodeficiency virus (HIV) infection who are …

Background Mortality within the first 6 months after initiating antiretroviral therapy is common
in resource-limited settings and is often due to tuberculosis in patients with advanced HIV …

Background Diabetes mellitus (DM) increases the risk of tuberculosis (TB) disease. Knowledge
of the impact of DM on TB treatment outcomes is primarily based on retrospective studies…

Background Few studies have evaluated the association between preexisting vitamin D
deficiency and incident tuberculosis (TB). We assessed the impact of baseline vitamins D levels …

Background Antimicrobial resistance (AMR) is a growing threat to newborns in low- and
middle-income countries (LMIC). Methods We performed a prospective cohort study in 3 tertiary …

Background The COVID‐19 pandemic has placed healthcare professionals (HCP) in stressful
circumstances with increased patient loads and a high risk of exposure. We sought to …

We provide an overview of the epidemiology and clinical course of mucormycosis in the
coronavirus disease (COVID-19) pandemic era. We conducted a retrospective chart review of …

Background Suboptimal exposure to antituberculosis (anti-TB) drugs has been associated
with unfavourable treatment outcomes. We aimed to investigate estimates and determinants …

Background. Maternal human immunodeficiency virus (HIV) RNA load, CD4 cell count,
breast-feeding, antiretroviral use, and malaria are well-established factors associated with mother…